Search

New Study explores clinical benefits of electron-beam IORT in the treatment of borderline resectable pancreatic cancer.

FLASH therapy delivers radiation at ultra-high dose rates up to 100 times faster compared to conventional radiation therapy. The first patient in the world to participate in a clinical trial of FLASH therapy has been enrolled.

This first FDA clearance represents a significant milestone for AI Metrics, where researchers have been seeking new ways to use CT scans for virtual liver biopsy. 

Study to Enroll 600 Patients and Evaluate Real-World Clinical and Patient Reported Outcomes Across All Brain Tumor Types

icotec announces the U.S. FDA 510(k) clearance to market the VADER® Pedicle - System for use with bone cement for augmentation or without.

OncoQuest Pharmaceuticals, Inc., has begun dosing patients in the USA for the Phase 3 clinical trial of its immunotherapeutic drug candidate oregovomab.

First randomized clinical trial demonstrating that CTC count may help personalize treatment choices 

A large, landmark study published in the American Cancer Society's prestigious journal 'Cancer Cytopathology' shows that a simple non-invasive blood test (liquid biopsy) can accurately differentiate between non-cancerous tumors versus cancerous growths. 

The Society of Interventional Radiology is pleased to announce that Keith M. Hume will join the organization on Jan. 15, 2021, as its new executive director. 

IO Learning spoke with Riccardo Lencioni, MD, FSIR, EBIR, regarding the trial design for the EMERALD-1 study, which was recently presented at CIO 2020 and was designated as a “CIO Best Poster.”